{
    "2018-07-17": [
        [
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：反弹紧握“创新+升级”主线 继续强调品牌OTC回暖机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新",
                        "升级",
                        "品牌OTC",
                        "回暖"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:震荡行情坚守绩优股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "震荡",
                        "绩优股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}